Metabolism: an important player in glioma survival and development
Discover Oncology · 22.10.2024 · 15 (1)
DOI: 10.1007/s12672-024-01402-5 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Discover Oncology, online erschienen am 22.10.2024. Verfasst von Ning Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Cancer Hospital of Dalian University of Technology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital…. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 237 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Clinical Capability Construction Project for Liaoning Provincial Hospitals.
Abstract (Originalsprache)
Gliomas are malignant tumors originating from both neuroglial cells and neural stem cells. The involvement of neural stem cells contributes to the tumor's heterogeneity, affecting its metabolic features, development, and response to therapy. This review provides a brief introduction to the importance of metabolism in gliomas before systematically categorizing them into specific groups based on their histological and molecular genetic markers. Metabolism plays a critical role in glioma biology, as tumor cells rely heavily on altered metabolic pathways to support their rapid growth, survival, and progression. Dysregulated metabolic processes, involving carbohydrates, lipids, and amino acids not only fuel tumor development but also contribute to therapy resistance and metastatic potential. By understanding these metabolic changes, key intervention points, such as mutations in genes like RTK, EGFR, RAS, and IDH can be identified, paving the way for novel therapeutic strategies. This review emphasizes the connection between metabolic pathways and clinical challenges, offering actionable insights for future research and therapeutic development in gliomas.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, Cancer Hospital of Dalian University of Technology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, No.44 Xiaoheyan Road, Shenyang, Dadong, 110042, P R Chin…
- Institute of Cancer Medicine, Dalian University of Technology, No.2 Linggong Road, Dalian, Ganjingzi, 116024, P R China.
- Institute of Cancer Medicine, Dalian University of Technology, No.2 Linggong Road, Dalian, Ganjingzi, 116024, P R China. xuhuizhe@cancerhosp-ln-cmu.com.
- Central Laboratory, Cancer Hospital of China Medical University, Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital & Institute, No.44 Xiaoheyan Road, Shenyang, Liaoning Province, 110042, P R C…
- Institute of Cancer Medicine, Dalian University of Technology, No.2 Linggong Road, Dalian, Ganjingzi, 116024, P R China. pzpy@163.com.
Förderung
- Clinical Capability Construction Project for Liaoning Provincial Hospitals
Zitieren
APA
Wang, N., Yuan, Y., Hu, T., Xu, H., & Piao, H. (2024). Metabolism: an important player in glioma survival and development. Discover Oncology, 15(1). https://doi.org/10.1007/s12672-024-01402-5
Vancouver
Wang N, Yuan Y, Hu T, Xu H, Piao H. Metabolism: an important player in glioma survival and development. Discover Oncology. 2024;15(1). doi:10.1007/s12672-024-01402-5
BibTeX
@article{Wang2024,
author = {Wang, Ning and Yuan, Yiru and Hu, Tianhao and Xu, Huizhe and Piao, Haozhe},
title = {Metabolism: an important player in glioma survival and development},
journal = {Discover Oncology},
year = {2024},
volume = {15},
number = {1},
doi = {10.1007/s12672-024-01402-5}
}
EUVIMED